GetTopicDetailResponse(id=d02396438f3, topicName=鈉-葡萄糖共轉運蛋白-2抑制劑, introduction=鈉-葡萄糖共轉運蛋白-2抑制劑, content=null, image=null, comments=0, allHits=1305, url=https://h5.medsci.cn/topic?id=96438, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=78559, tagList=[TagDto(tagId=78559, tagName=鈉-葡萄糖共轉運蛋白-2抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2257872, encodeId=fd98225e8721d, content=<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a> <a href='/topic/show?id=d02396438f3' target=_blank style='color:#2F92EE;'>#鈉-葡萄糖共轉運蛋白-2抑制劑#</a>, objectTitle=JAHA：鈉-葡萄糖共轉運蛋白-2抑制劑治療心力衰竭的時機和依從性, objectType=article, longId=868778, objectId=5895868e78df, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241111/1731295273014_8538692.png, objectUrl=/article/show_article.do?id=5895868e78df, replyNumber=0, likeNumber=40, createdTime=2025-03-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=5895868e78df, moduleTitle=JAHA：鈉-葡萄糖共轉運蛋白-2抑制劑治療心力衰竭的時機和依從性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5895868e78df)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195009, encodeId=4d81219500940, content=<a href='/topic/show?id=d02396438f3' target=_blank style='color:#2F92EE;'>#鈉-葡萄糖共轉運蛋白-2抑制劑#</a> <a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=b0885428229' target=_blank style='color:#2F92EE;'>#房顫風險#</a>, objectTitle=Eur Heart J-Card Pha：鈉-葡萄糖共轉運蛋白-2抑制劑與2型糖尿病患者房顫風險的關系, objectType=article, longId=817801, objectId=aee081e801aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240323/1711171921894_1739456.jpg, objectUrl=/article/show_article.do?id=aee081e801aa, replyNumber=0, likeNumber=156, createdTime=2024-03-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=aee081e801aa, moduleTitle=Eur Heart J-Card Pha：鈉-葡萄糖共轉運蛋白-2抑制劑與2型糖尿病患者房顫風險的關系, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aee081e801aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176353, encodeId=e0b621e6353bf, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=2ad5104395dc' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a> <a href='/topic/show?id=d02396438f3' target=_blank style='color:#2F92EE;'>#鈉-葡萄糖共轉運蛋白-2抑制劑#</a>, objectTitle=Diabetes Obes Metab?：鈉-葡萄糖共轉運蛋白-2抑制劑停藥后的預測因素, objectType=article, longId=806340, objectId=25f280634003, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221115/1668549971209_4754896.webp, objectUrl=/article/show_article.do?id=25f280634003, replyNumber=0, likeNumber=146, createdTime=2023-12-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=25f280634003, moduleTitle=Diabetes Obes Metab?：鈉-葡萄糖共轉運蛋白-2抑制劑停藥后的預測因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=25f280634003)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
